» Articles » PMID: 34538961

Green Hope: Perspectives on Cannabis from People Who Use Opioids

Overview
Journal Sociol Inq
Date 2021 Sep 20
PMID 34538961
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

While states are implementing policies to legalize cannabis for medical or recreational purposes, it remains a Schedule 1 controlled substance with no medical uses according to US federal law. The perception of cannabis depends on social and cultural norms that impact political institutions involved in implementing policy. Because of negative social constructions, such as the "gateway hypothesis," legalization of cannabis has been slow and contentious. Recent studies suggest that cannabis can help combat the opioid epidemic. This paper fills a gap in our understanding of how cannabis is viewed by people who are actively misusing opioids and not in treatment. Using ethnographic methods to recruit participants living in a state that legalized cannabis and a state where cannabis was illegal, survey and interview data were analyzed informed by a social constructionist lens. Findings from their "insider perspective" suggest that for some people struggling with problematic opioid use, cannabis can be beneficial.

Citing Articles

A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids.

Heal D, Gosden J, Smith S Front Psychiatry. 2024; 15:1322434.

PMID: 38915848 PMC: 11194422. DOI: 10.3389/fpsyt.2024.1322434.


MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events.

To J, Davis M, Sbrana A, Alderman B, Hui D, Mukhopadhyay S Support Care Cancer. 2023; 31(4):202.

PMID: 36872397 DOI: 10.1007/s00520-023-07662-1.


The Cannabis-Dependent Relationship Between Methadone Treatment Dose and Illicit Opioid Use in a Community-Based Cohort of People Who Use Drugs.

Lake S, Kerr T, Buxton J, Walsh Z, Cooper Z, Socias M Cannabis Cannabinoid Res. 2021; 8(1):155-165.

PMID: 34813374 PMC: 9940808. DOI: 10.1089/can.2021.0080.

References
1.
Lopez A, Bourgois P, Wenger L, Lorvick J, Martinez A, Kral A . Interdisciplinary mixed methods research with structurally vulnerable populations: case studies of injection drug users in San Francisco. Int J Drug Policy. 2013; 24(2):101-9. PMC: 3954115. DOI: 10.1016/j.drugpo.2012.12.004. View

2.
Belendiuk K, Baldini L, Bonn-Miller M . Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. Addict Sci Clin Pract. 2015; 10:10. PMC: 4636852. DOI: 10.1186/s13722-015-0032-7. View

3.
Swartz R . Medical marijuana users in substance abuse treatment. Harm Reduct J. 2010; 7:3. PMC: 2848643. DOI: 10.1186/1477-7517-7-3. View

4.
Degenhardt L, Coffey C, Romaniuk H, Swift W, Carlin J, Hall W . The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood. Addiction. 2012; 108(1):124-33. DOI: 10.1111/j.1360-0443.2012.04015.x. View

5.
Whalen T, Boeri M . Measuring Discontinuity in Binary Longitudinal Data: Applications to Drug Use Trajectories. Sociol Methods Res. 2014; 43(2):248-279. PMC: 4190590. DOI: 10.1177/0049124113511594. View